So far, the tumor suppressor function of miR‐15/16, which targets important drivers of malignant growth such as FGF2 and the anti‐apoptotic protein Bcl‐2 (He et al., 2016; Willimott and Wagner, 2010), has been well established in various tumor types including prostate, lung, ovarian, and MPM (Bandi et al., 2009; Bhattacharya et al., 2009; Bonci et al., 2008; Reid et al., 2013). The gene discussed is BCL2; the disease is neoplasm.